Education
About Us
Working with TipRanks
Follow Us
Prophase Labs (PRPH)
NASDAQ:PRPH
PRPH Stock Chart & Stats
$0.41
-$0.13(-18.06%)
At close: 4:00 PM EST
$0.41
-$0.13(-18.06%)
Day’s Range― - ―
52-Week Range$0.22 - $2.50
Previous CloseN/A
Volume469.10K
Average Volume (3M)2.72M
Market Cap
$20.77M
Enterprise Value$23.95M
Total Cash (Recent Filing)$171.00K
Total Debt (Recent Filing)$5.54M
Price to Earnings (P/E)―
Beta1.65
Next Earnings
Nov 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 24, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding41,541,206
10 Day Avg. Volume1,358,998
30 Day Avg. Volume2,724,170
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue7.17
Enterprise Value/Gross Profit11.86
Enterprise Value/Ebitda-0.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Prophase Labs News
PRPH FAQ
What was Prophase Labs’s price range in the past 12 months?
Prophase Labs lowest stock price was $0.22 and its highest was $2.50 in the past 12 months.
What is Prophase Labs’s market cap?
Prophase Labs’s market cap is $20.77M.
When is Prophase Labs’s upcoming earnings report date?
Prophase Labs’s upcoming earnings report date is Nov 06, 2025 which is in 13 days.
How were Prophase Labs’s earnings last quarter?
Prophase Labs released its earnings results on Aug 13, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.15 by $0.04.
Is Prophase Labs overvalued?
According to Wall Street analysts Prophase Labs’s price is currently Overvalued.
Does Prophase Labs pay dividends?
Prophase Labs pays a Notavailable dividend of $0.3 which represents an annual dividend yield of N/A. See more information on Prophase Labs dividends here
What is Prophase Labs’s EPS estimate?
Prophase Labs’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Prophase Labs have?
Prophase Labs has 41,541,206 shares outstanding.
What happened to Prophase Labs’s price movement after its last earnings report?
Prophase Labs reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.15. Following the earnings report the stock price went down -5.714%.
Which hedge fund is a major shareholder of Prophase Labs?
Currently, no hedge funds are holding shares in PRPH
Company Description
Prophase Labs
Prophase Labs (PRPH) is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions for various medical conditions. The company operates primarily in the healthcare sector, with a strong emphasis on diagnostics and treatments for infectious diseases, particularly in the fields of respiratory and viral infections. Prophase Labs is known for its proprietary technologies and products that aim to improve patient outcomes and enhance the efficiency of healthcare delivery.
PRPH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call provided a mix of optimistic future prospects and current financial challenges. While there are significant potential opportunities, such as large cash recovery and new ventures, there are also current concerns regarding stock performance and financial stability.View all PRPH earnings summariesTechnical Analysis
Ownership Overview
9.29%
Insiders
1.58% Mutual Funds
0.19% Other Institutional Investors
88.26% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---